Hims & Hers Health Reports Better-Than-Expected Q2 Results: Details
Portfolio Pulse from Erica Kollmann
Hims & Hers Health, Inc. (NYSE:HIMS) reported better-than-expected Q2 results with earnings of 6 cents per share and sales of $315.648 million, both beating analyst estimates. The company saw a 51.82% increase in sales year-over-year and a significant rise in free cash flow. Despite the positive results, HIMS shares fell 10.59% after-hours.
August 05, 2024 | 8:26 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Hims & Hers Health reported strong Q2 results, beating analyst estimates with earnings of 6 cents per share and sales of $315.648 million. Despite the positive financial performance, the stock fell 10.59% after-hours.
The company reported better-than-expected earnings and sales, indicating strong financial health and growth. However, the after-hours stock price drop suggests that investors may have had higher expectations or concerns about future performance.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100